Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Nu-Med Plus (NUMD) Invested Capital (2016 - 2021)

Nu-Med Plus' Invested Capital history spans 10 years, with the latest figure at -$70017.0 for Q3 2021.

  • Quarterly results put Invested Capital at -$70017.0 for Q3 2021, down 120.71% from a year ago — trailing twelve months through Sep 2021 was -$70017.0 (down 120.71% YoY), and the annual figure for FY2020 was $467703.0, up 282.55%.
  • Invested Capital for Q3 2021 was -$70017.0 at Nu-Med Plus, down from -$1651.0 in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $523860.0 in Q2 2020 to a low of -$307254.0 in Q2 2019.
  • The 5-year median for Invested Capital is -$11625.0 (2018), against an average of $18543.9.
  • The sharpest move saw Invested Capital crashed 1891.28% in 2019, then skyrocketed 282.55% in 2020.
  • Year by year, Invested Capital stood at $77641.0 in 2017, then dropped by 23.38% to $59486.0 in 2018, then crashed by 530.69% to -$256201.0 in 2019, then skyrocketed by 282.55% to $467703.0 in 2020, then plummeted by 114.97% to -$70017.0 in 2021.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$70017.0, -$1651.0, and $190955.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.